This brand name is authorized in Australia, Austria, Brazil, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.
The drug TRIMBOW contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
5B307S63B2 - BECLOMETHASONE DIPROPIONATE
|
|
Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. |
|
2
|
UNII
W34SHF8J2K - FORMOTEROL FUMARATE
|
|
Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge. |
|
3
|
UNII
A14FB57V1D - GLYCOPYRRONIUM
|
|
Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R03AL09 | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 12468F |
| BR | Câmara de Regulação do Mercado de Medicamentos | 508520050012707, 508520050012807 |
| EE | Ravimiamet | 1750216, 1750227, 1750238, 1750249, 1750250, 1837694, 1837706, 1837717, 1837728, 1845468, 1845479, 1845480 |
| ES | Centro de información online de medicamentos de la AEMPS | 1171208002 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 026496, 179955, 395923, 449455 |
| FR | Base de données publique des médicaments | 66710887 |
| GB | Medicines & Healthcare Products Regulatory Agency | 346817 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 8805 |
| IT | Agenzia del Farmaco | 045489010, 045489022, 045489034, 045489046, 045489059, 045489061, 045489073, 045489085, 045489097, 045489109, 045489111, 045489123 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1083425, 1083426, 1083427, 1083428, 1083429, 1091780, 1091781, 1091783, 1091784, 1092403, 1092404, 1092421 |
| NL | Z-Index G-Standaard, PRK | 146749, 199249 |
| PL | Rejestru Produktów Leczniczych | 100392327, 100463074 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W63847001, W63847002, W67900001, W67900002, W67900003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.